ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,572.85
      0.10%
      US Tech 100
      19,963.60
      0.59%
      Dow Jones
      39,344.79
      -0.08%
      Brent Oil
      85.505
      0.11%
      Bitcoin
      57,381.08
      1.19%
      Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. InMed Pharmaceuticals Inc (INM)

      7. InMed Pharmaceuticals Inc (INM) News

      INM

      InMed Pharmaceuticals (INM)

      InMed Pharmaceuticals Inc
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:INM
      DateTimeSourceHeadlineSymbolCompany
      10/27/20234:08PMEdgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:INMInMed Pharmaceuticals Inc
      10/27/20234:04PMEdgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:INMInMed Pharmaceuticals Inc
      10/24/20234:18PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:INMInMed Pharmaceuticals Inc
      09/29/20235:18PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:INMInMed Pharmaceuticals Inc
      09/29/202311:43AMEdgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:INMInMed Pharmaceuticals Inc
      09/29/202311:30AMEdgar (US Regulatory)Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405NASDAQ:INMInMed Pharmaceuticals Inc
      09/25/20234:12PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:INMInMed Pharmaceuticals Inc
      08/31/20235:22PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:INMInMed Pharmaceuticals Inc
      07/24/20234:26PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:INMInMed Pharmaceuticals Inc
      07/20/20232:18PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:INMInMed Pharmaceuticals Inc
      05/25/202312:37PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:INMInMed Pharmaceuticals Inc
      05/19/20231:42PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:INMInMed Pharmaceuticals Inc
      05/16/20236:00PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:INMInMed Pharmaceuticals Inc
      05/16/20235:59PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:INMInMed Pharmaceuticals Inc
      05/16/20231:48PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:INMInMed Pharmaceuticals Inc
      05/15/202311:47AMEdgar (US Regulatory)Quarterly Report (10-q)NASDAQ:INMInMed Pharmaceuticals Inc
      03/28/20231:41PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:INMInMed Pharmaceuticals Inc
      03/10/20238:35AMGlobeNewswire Inc.Life Sciences Virtual Investor Forum: Presentations Now Available for Online ViewingNASDAQ:INMInMed Pharmaceuticals Inc
      03/09/20233:47PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:INMInMed Pharmaceuticals Inc
      03/09/20233:44PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:INMInMed Pharmaceuticals Inc
      03/07/20234:01PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:INMInMed Pharmaceuticals Inc
      03/07/20238:35AMGlobeNewswire Inc.Life Sciences Virtual Investor Forum Agenda Announced for March 9thNASDAQ:INMInMed Pharmaceuticals Inc
      02/20/202311:00AMGlobeNewswire Inc.InMed Reports Second Quarter Fiscal 2023 Financial Results and Provides Business UpdateNASDAQ:INMInMed Pharmaceuticals Inc
      02/14/202312:59PMEdgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:INMInMed Pharmaceuticals Inc
      02/10/20236:09AMEdgar (US Regulatory)Notification That Quarterly Report Will Be Submitted Late (nt 10-q)NASDAQ:INMInMed Pharmaceuticals Inc
      02/09/20239:40PMGlobeNewswire Inc.InMed Submits Form 12b-25NASDAQ:INMInMed Pharmaceuticals Inc
      01/10/20237:30AMGlobeNewswire Inc.InMed Provides Business Update and Milestones for 2023NASDAQ:INMInMed Pharmaceuticals Inc
      12/19/20225:05PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:INMInMed Pharmaceuticals Inc
      12/19/20225:00PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:INMInMed Pharmaceuticals Inc
      12/19/20224:59PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:INMInMed Pharmaceuticals Inc
       Showing the most relevant articles for your search:NASDAQ:INM

      Your Recent History

      BIT
      NSCIT29874Q4
      European Bank for Recons...
      NYSE
      AC
      Associated Capital
      Delayed Upgrade Clock